Kriya Therapeutics, Inc.
Clinical trials sponsored by Kriya Therapeutics, Inc., explained in plain language.
-
Can a single gene therapy injection reverse fatty liver disease?
Disease control Recruiting nowThis trial tests an experimental gene therapy called VV-14303 for people with metabolic dysfunction-associated steatohepatitis (MASH), a serious liver condition linked to obesity and diabetes. The therapy uses a harmless virus to deliver a protein (FGF21) that may improve liver h…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy shot around the eye aims to reduce bulging in thyroid eye disease
Disease control Recruiting nowThis study tests a new gene therapy called VV-14305, given as an injection around the eye, for people with moderate to severe thyroid eye disease. The trial will include 110 adults and is split into two parts: first to check safety, then to compare the treatment against a sham in…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Gene therapy injection aims to slow vision loss from dry AMD
Disease control Recruiting nowThis study tests a new gene therapy (VV-14295) given as an injection into the eye for people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes blind spots. The goal is to see if it is safe and can slow the growth of these blind spots. Ab…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New combo therapy aims to calm face pain attacks
Symptom relief Recruiting nowThis early-stage study tests whether an injection of RP-008 followed by a daily varenicline pill is safe and can reduce pain for people with trigeminal neuralgia, a condition causing severe facial pain attacks. About 24 adults aged 18-80 with classic or idiopathic trigeminal neur…
Phase 1/2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC